Vaxcyte
Price & Volume
Stats
See more52W Range | $58.10-$121.05 |
Market Cap | $9.2B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$75M |
Diluted EPS | -$3.80 |
News
See moreYahoo Finance • 29 days ago
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Yahoo Finance • 2 months ago
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Yahoo Finance • 2 months ago
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
About
CEO | Mr. Grant E. Pickering M.B.A. |
CFO | Mr. Andrew L. Guggenhime M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 414 |
